| Dr James L Milhollin, MD | |
|
266 Joule St, Alcoa, TN 37701-2422 | |
| (865) 984-3864 | |
| (865) 380-4095 |
| Full Name | Dr James L Milhollin |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 24 Years |
| Location | 266 Joule St, Alcoa, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457438525 | NPI | - | NPPES |
| 3869773 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 35521 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Care | Knoxville, TN | Home health agency |
| Blount Memorial Home Health | Maryville, TN | Home health agency |
| Blount Memorial Hospital | Maryville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blount Memorial Physician Group Inc | 6406844174 | 242 |
News Archive
f-star Biotechnologische Forschungs-und Entwicklungsges.m.b.H today announced the signing of a collaboration and license agreement with Boehringer Ingelheim for joint discovery of new antibody-derived therapeutic products based on f-star's Modular Antibody Technology.
Sodium channels are implicated in many serious conditions such as heart disease, epilepsy and pain, making them an important potential target for drug therapies. Unfortunately, there is still much scientists do not know about the molecules.
Amorfix Life Sciences and QED Bioscience announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Under the agreement, QED will generate monoclonal antibodies against several disease specific epitopes on misfolded CD38 protein. The DSE's were identified by Amorfix using their proprietary ProMIS computational platform discovery technology.
An electronic system that monitors how physicians give blood to patients after an operation has enabled a 22-hospital system with thousands of doctors to significantly reduce the amount of blood transfusions patients receive, cutting costs by $2.5 million over two years and contributing to lower infection rates without harming patients, according to a study presented at the 2015 Clinical Congress of the American College of Surgeons.
New research from the Howard Florey Institute in Melbourne has shown why mutation in a single gene can cause epilepsy in infants.
› Verified 4 days ago
| Entity Name | Blount Memorial Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699710194 PECOS PAC ID: 6406844174 Enrollment ID: O20040503000547 |
News Archive
f-star Biotechnologische Forschungs-und Entwicklungsges.m.b.H today announced the signing of a collaboration and license agreement with Boehringer Ingelheim for joint discovery of new antibody-derived therapeutic products based on f-star's Modular Antibody Technology.
Sodium channels are implicated in many serious conditions such as heart disease, epilepsy and pain, making them an important potential target for drug therapies. Unfortunately, there is still much scientists do not know about the molecules.
Amorfix Life Sciences and QED Bioscience announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Under the agreement, QED will generate monoclonal antibodies against several disease specific epitopes on misfolded CD38 protein. The DSE's were identified by Amorfix using their proprietary ProMIS computational platform discovery technology.
An electronic system that monitors how physicians give blood to patients after an operation has enabled a 22-hospital system with thousands of doctors to significantly reduce the amount of blood transfusions patients receive, cutting costs by $2.5 million over two years and contributing to lower infection rates without harming patients, according to a study presented at the 2015 Clinical Congress of the American College of Surgeons.
New research from the Howard Florey Institute in Melbourne has shown why mutation in a single gene can cause epilepsy in infants.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James L Milhollin, MD 103 W Broadway Ave, Maryville, TN 37801-4703 Ph: (865) 273-1752 | Dr James L Milhollin, MD 266 Joule St, Alcoa, TN 37701-2422 Ph: (865) 984-3864 |
News Archive
f-star Biotechnologische Forschungs-und Entwicklungsges.m.b.H today announced the signing of a collaboration and license agreement with Boehringer Ingelheim for joint discovery of new antibody-derived therapeutic products based on f-star's Modular Antibody Technology.
Sodium channels are implicated in many serious conditions such as heart disease, epilepsy and pain, making them an important potential target for drug therapies. Unfortunately, there is still much scientists do not know about the molecules.
Amorfix Life Sciences and QED Bioscience announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Under the agreement, QED will generate monoclonal antibodies against several disease specific epitopes on misfolded CD38 protein. The DSE's were identified by Amorfix using their proprietary ProMIS computational platform discovery technology.
An electronic system that monitors how physicians give blood to patients after an operation has enabled a 22-hospital system with thousands of doctors to significantly reduce the amount of blood transfusions patients receive, cutting costs by $2.5 million over two years and contributing to lower infection rates without harming patients, according to a study presented at the 2015 Clinical Congress of the American College of Surgeons.
New research from the Howard Florey Institute in Melbourne has shown why mutation in a single gene can cause epilepsy in infants.
› Verified 4 days ago
Dr. John J Ingram Iii, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 266 Joule St, Alcoa, TN 37701 Phone: 865-984-3864 Fax: 865-380-4095 | |
Dr. Richard M Gaddis, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 266 Joule St, Alcoa, TN 37701 Phone: 865-984-3864 Fax: 865-380-4095 | |
Richard A Savell, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 266 Joule St, Alcoa, TN 37701 Phone: 865-984-3864 Fax: 865-380-4095 | |
Dr. Renee Joy Hyatt, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 255 E Watt St, Alcoa, TN 37701 Phone: 865-273-1616 Fax: 865-273-1645 | |
Dr. Jayraj F Jhala, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 266 Joule St, Alcoa, TN 37701 Phone: 865-984-3864 Fax: 865-380-4095 | |
Mrs. Jennifer L Best, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 266 Joule St, Alcoa, TN 37701 Phone: 865-984-3864 Fax: 865-380-4095 | |
Dr. Jeffrey S Scheib, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 266 Joule St, Alcoa, TN 37701 Phone: 865-984-3864 Fax: 865-380-4095 |